MentionFox
Home › funding signals › Quince Therapeutics, Inc.
Company · SEC filings

Quince Therapeutics, Inc. funding history

Quince Therapeutics, Inc. has 3 Form D filings on record, from 2025-07-01 to 2026-06-11. Together its new offerings report $126.21M sold.

Funding historyFounders and team

What do you want to do with Quince Therapeutics, Inc.?

Based
South San Francisco, CALIFORNIA
Industry group
Biotechnology
Filings
3
Raised (new offerings)
$126.21M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-06-11New offering
first sale 2026-05-18
$114.72M$186.42Mdetails · SEC filing
2026-06-11New offering
first sale 2026-05-18
$0$7.39Mdetails · SEC filing
2025-07-01New offering
first sale 2025-06-18
$11.49M$21.90MSEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Quince Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Leadership changes

5%+ stakes

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Quince Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/quince-therapeutics-inc
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3
Quince Therapeutics, Inc. funding history: 3 SEC filings, $126.21M raised. MentionFox, 2026-09-27. https://mentionfox.com/company/quince-therapeutics-inc